Ahmet Cumaoğlu

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsHaematological tumoursFree radical chemistryEcosystem services (incl. pollination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 14, 2025
Effects of empagliflozin and its combination with docetaxel on LNCaP and DU- 145 prostate cancer cell lines: cytotoxicity and molecular pathway analysis.

Ahmet Cumaoğlu, Selda Nur Akdeniz, Ahmad Karzoon

|Jul 27, 2024
Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.

Ahmad Karzoon, Mükerrem Betül Yerer, Ahmet Cumaoğlu

|Mar 13, 2023
An evaluation of the effects on the ovaries of hyperbaric oxygen therapy in a rat model of premature ovarian failure created with cyclophosphamide.

Fulya Çağlı, Mehmet Akif Baktır, Mehmet Dolanbay

|Aug 31, 2021
Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β-catenin signaling pathways.

Büşra Karaca, Elçin Bakır, Mükerrem Betül Yerer

|May 27, 2020
Anti-inflammatory Effects of Pelargonium endlicherianum Fenzl. Extracts in Lipopolysaccharide-stimulated Macrophages.

Ahmet Cumaoğlu, Gökçe Şeker Karatoprak, Mükerrem Betül Yerer

Pageof 1